Hemodialysis following butoxyethanol ingestion.
This case report describes a 19-year-old male who ingested a product containing butoxyethanol, propylene glycol, and monoethanolamine. Neurotoxicity, acidosis, and butoxyacetic acid persisted after hemodialysis. Hemodialysis was used to treat the acidosis, but the half-life of butoxyacetic acid did not appear to have been significantly altered. Fomepizole, a recently approved alcohol dehydrogenase inhibitor for ethylene glycol intoxication, was not available at the time of this case. Residual neurological deficits persisted after recovery from this severe intoxication by a glycol ether.
Burkhart
K K
KK
Central Pennsylvania Poison Center, Penn State Geisinger Health System, Hershey 17033-0850, USA. kkb3@psu.edu
Donovan
J W
JW
D000328:Adult; D003422:Critical Care; D005026:Ethylene Glycols / Q000506:poisoning*; D006801:Humans; D008297:Male; D011041:Poisoning / Q000628:therapy; D006435:Renal Dialysis; D012997:Solvents / Q000506:poisoning*; D013064:Speech Disorders / Q000139:chemically induced
D005026:Ethylene Glycols; D012997:Solvents; C017096:n-butoxyethanol